Activation of Phospholipase Cbeta by G Proteins

G 蛋白对磷脂酶 Cbeta 的激活

基本信息

项目摘要

DESCRIPTION (provided by applicant): P.I. S. Scarlata Phospholipase C-b (PLC?) enzymes are activated by G proteins in response to agents such as hormones and neurotransmitters. PLC? activity causes an increase in intracellular calcium which ultimately leads to profound changes in the cell. Our lab has focused on the mechanism through which G proteins activate PLC? on the molecular level. However, in cultured cells, we find additional and unexpected mechanisms of regulation. First, membrane domains called caveolae can control the duration of PLC? activation by selectively sequestering G protein activators. 1 - In AIM 1, we will use live cell imaging and state of the art fluorescence methods to determine the mechanisms through which caveolae prolongs PLC? - mediated calcium signals and directs signals along specific cellular pathways. 2- We have found that PLCb localizes to the nucleus and cytosol as well as the plasma membrane where its G protein activators are found. We have identified a novel protein partner of PLC? translin-associated protein X (TRAX). TRAX and its partner translin are major components of the siRNA machinery regulating the cellular levels of proteins. In AIM 2, we will determine the ability of TRAX to deliver PLC? from the nucleus to the plasma membrane upon G protein activation. In parallel, we will determine whether PLC affects translin-TRAX function. 3- The ability of PLC? to generate signals depends on its cellular concentration. We have found that the synucleins can binds to and stabilize PLC? in cells. Alpha-synuclein (AS) is a small unfolded protein of unknown function and is a major component of neurodegenerative plaques. The presence of AS greatly increases PLC? levels, and we find that down-regulation of PLC??causes AS aggregation. Also, gamma- synuclein (GS), the protein encoded by the breast cancer susceptibility gene 1, appears to increase PLCb -mediated migration and cell invasiveness thereby promoting breast cancer. In AIM 3 we will better define PLC? - synuclein interactions and develop reagents that prevent AS aggregation and reduce GS-induced breast cancer phenotype. PUBLIC HEALTH RELEVANCE: P.I. Scarlata, S. Project Narrative In cells, enzymes are subject to other forms of regulation that are distinct and not seen in vitro. Here, we will continue our studies of the activation of phopsholipase C-2 (PLC2) focusing on its cellular regulation which may be applicable to other enzymes. Importantly, the link between PLC2 and synucleins in promoting neurodegenerative disease and breast cancer will be explored to develop more effective therapeutics.
描述(由申请人提供):P.I. s.s Scarlata磷脂酶C-b (PLC?)酶被G蛋白激活,以响应激素和神经递质等药物。PLC ?活动引起细胞内钙的增加,最终导致细胞的深刻变化。我们的实验室一直致力于研究G蛋白激活PLC?在分子水平上。然而,在培养细胞中,我们发现了额外的和意想不到的调节机制。首先,称为小泡的膜结构域可以控制PLC?通过选择性隔离G蛋白激活剂进行激活。1 -在AIM 1中,我们将使用活细胞成像和最先进的荧光方法来确定小泡延长PLC?介导的钙信号,并沿着特定的细胞途径指导信号。2-我们已经发现PLCb定位于细胞核和细胞质溶胶以及发现其G蛋白激活剂的质膜。我们发现了一种新的PLC?翻译蛋白相关蛋白X (TRAX)。TRAX及其伙伴translin是siRNA机制调节细胞蛋白水平的主要组成部分。在AIM 2中,我们将确定TRAX交付PLC的能力。通过G蛋白激活从细胞核到质膜。同时,我们将确定PLC是否影响translin-TRAX功能。PLC的能力?产生信号取决于它的细胞浓度。我们发现共核蛋白可以结合并稳定PLC?在细胞。α -突触核蛋白(AS)是一种功能未知的小折叠蛋白,是神经退行性斑块的主要成分。AS的存在大大增加了PLC?水平,我们发现PLC下调??导致AS聚合。此外,由乳腺癌易感基因1编码的γ -突触核蛋白(GS)似乎增加了PLCb介导的迁移和细胞侵袭性,从而促进了乳腺癌。在AIM 3中,我们将更好地定义PLC?-突触核蛋白相互作用,并开发试剂,防止AS聚集和减少gs诱导的乳腺癌表型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Suzanne F Scarlata其他文献

Suzanne F Scarlata的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Suzanne F Scarlata', 18)}}的其他基金

Role of caveolae in G protein signaling
小凹在 G 蛋白信号传导中的作用
  • 批准号:
    9210145
  • 财政年份:
    2015
  • 资助金额:
    $ 31.4万
  • 项目类别:
Activation of Phospholipase C beta by G Proteins
G 蛋白激活磷脂酶 C beta
  • 批准号:
    7878896
  • 财政年份:
    2009
  • 资助金额:
    $ 31.4万
  • 项目类别:
UNDERSTANDING RECEPTOR AND G PROTEIN INTERACTIONS IN LIVE CELLS
了解活细胞中受体和 G 蛋白的相互作用
  • 批准号:
    7956560
  • 财政年份:
    2009
  • 资助金额:
    $ 31.4万
  • 项目类别:
UNDERSTANDING RECEPTOR AND G PROTEIN INTERACTIONS IN LIVE CELLS
了解活细胞中受体和 G 蛋白的相互作用
  • 批准号:
    7724074
  • 财政年份:
    2008
  • 资助金额:
    $ 31.4万
  • 项目类别:
FASEB Summer Conference on Phospholipases
FASEB 磷脂酶夏季会议
  • 批准号:
    7614204
  • 财政年份:
    2006
  • 资助金额:
    $ 31.4万
  • 项目类别:
FASEB Summer Conference on Phospholipases
FASEB 磷脂酶夏季会议
  • 批准号:
    7413738
  • 财政年份:
    2006
  • 资助金额:
    $ 31.4万
  • 项目类别:
FASEB Summer Conference on Phospholipases
FASEB 磷脂酶夏季会议
  • 批准号:
    7247876
  • 财政年份:
    2006
  • 资助金额:
    $ 31.4万
  • 项目类别:
PHYSICAL ELUCIDATION OF VIRUS ASSEMBLY
病毒组装的物理解析
  • 批准号:
    6181064
  • 财政年份:
    1998
  • 资助金额:
    $ 31.4万
  • 项目类别:
PHYSICAL ELUCIDATION OF VIRUS ASSEMBLY
病毒组装的物理解析
  • 批准号:
    2698727
  • 财政年份:
    1998
  • 资助金额:
    $ 31.4万
  • 项目类别:
PHYSICAL ELUCIDATION OF VIRUS ASSEMBLY
病毒组装的物理解析
  • 批准号:
    6384328
  • 财政年份:
    1998
  • 资助金额:
    $ 31.4万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 31.4万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 31.4万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 31.4万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 31.4万
  • 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Idea to Innovation
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了